Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center is recorded as a service provider in 3 clinical trials. Explore its recorded services, study phases and therapeutic areas, with trial-level operational learnings where available.
Clinical trial experience
Showing 3 of 3 trials · Latest update first
Multicenter Phase 3 Pivotal Study to Evaluate the Safety and Efficacy of TOOKAD (padeliporfin) Vascular Targeted Photodynamic Therapy in the Treatment of Low-Grade Upper Tract Urothelial Cancer
Sponsor Steba Biotech S.A.
- Start (EU)
- Latest update
- Estimated end
Phase 2b Clinical Study Evaluating Efficacy and Safety of TAR-200 in Combination with Cetrelimab, TAR-200 Alone, or Cetrelimab Alone in Participants with High-Risk Non- Muscle Invasive Bladder Cancer (NMIBC) Unresponsive to Intravesical Bacillus Calmette- Guérin (BCG) who are Ineligible for or Elected Not to Undergo Radical Cystectomy
Sponsor Janssen - Cilag International
- Start (EU)
- Latest update
- Estimated end
A Phase 1/2, Open-label Study of Nivolumab Monotherapy or Nivolumab combined with Ipilimumab in Subjects with Advanced or Metastatic Solid Tumors
Sponsor Bristol Myers Squibb International Corporation
- Start (EU)
- Latest update
- Estimated end
Questions about this trial experience
What services are recorded for Memorial Sloan Kettering Cancer Center?
The 2026-10-09 snapshot links Memorial Sloan Kettering Cancer Center to 3 distinct CTIS trials. Recorded services include Genomic, histopathology, Laboratory services, Peripheral blood-based biomarker analysis in patients with advanced solid tumors. These are study-specific roles, not a complete or independently verified capability catalogue.
Which therapeutic areas and study phases are recorded for Memorial Sloan Kettering Cancer Center?
The most frequently recorded therapeutic areas are Solid Tumor Oncology, Urology. Recorded phases include Phase 3. Use the filters to inspect the supporting studies; missing tags are not evidence of absent experience.
In which countries are trials linked to Memorial Sloan Kettering Cancer Center conducted?
The linked trials record locations in 9 countries, including Germany, Spain, France, Italy, Austria. These are trial locations, not confirmed office locations or countries where Memorial Sloan Kettering Cancer Center delivered services.
What can this page tell me about Memorial Sloan Kettering Cancer Center's trial experience?
Browse 3 distinct trials with recorded roles, sponsor names, available study dates and links to CTIS source records. No trial-level operational findings are recorded in this snapshot. Trial counts and findings do not measure the provider’s performance or establish responsibility for study outcomes.
About this data & company names
One current approved profile per CTIS trial. Services reflect recorded roles, not a complete capability catalogue or a performance ranking. Missing tags mean the information was not recorded. Country tags describe trial locations, not the provider’s service territory.
Start is the reported EU start date; latest update is the CTIS publication date; estimated end is the reported global estimate, which may be in the past. Missing dates are shown as “Not reported”. Operational learnings describe the trial as a whole and do not establish the provider’s responsibility.
Clear service synonyms are grouped; otherwise the source label is retained. Service tags show the recorded roles for each trial. This page groups 1 recorded name variant under Memorial Sloan Kettering Cancer Center. Legacy brands remain separate unless explicitly matched in the name registry.
View recorded company names
- Memorial Sloan Kettering Cancer Center